{"id":"W2908699784","doi":"10.1007/s10549-018-05125-4","title":"Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":442,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; University of Alberta","funders":"Pfizer","keywords":"Palbociclib; Letrozole; Medicine; Breast cancer; Oncology; Internal medicine; Placebo; Metastatic breast cancer; Hazard ratio; Estrogen receptor; Population; Cancer; Gynecology; Tamoxifen; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002174952,0.0007823654,0.001138012,0.0004373759,0.000403417,0.00008786599,0.0002521074,0.0001901301,0.003729091],"category_scores_gemma":[0.00001754942,0.0005576864,0.0001813058,0.0008662533,0.0005710067,0.0005514957,0.0001106678,0.0006400673,0.000103425],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003728239,"about_ca_system_score_gemma":0.001206885,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01750112,"about_ca_topic_score_gemma":0.003204925,"domain_scores_codex":[0.9952238,0.000254408,0.0005185457,0.001367177,0.001116753,0.001519341],"domain_scores_gemma":[0.9973221,0.0002773862,0.0002136756,0.0006325006,0.0008238278,0.000730493],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.09151347,0.002199138,0.3704019,0.0002433163,0.002396397,0.0002487898,0.004044095,0.0001154091,0.0238848,0.0005213197,0.0001098071,0.5043216],"study_design_scores_gemma":[0.08115394,0.01076672,0.8512605,0.001912315,0.0001017267,0.000565167,0.001858929,0.00005255242,0.04795021,0.0005147713,0.002721851,0.001141315],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9814484,0.0040643,0.0000119581,0.008308101,0.0001797214,0.00351664,0.001971886,0.0001140568,0.0003849991],"genre_scores_gemma":[0.9854721,0.007076696,0.0003183621,0.0002381077,0.0004247411,0.002688947,0.0001692717,0.0001693882,0.003442337],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5031803,"threshold_uncertainty_score":0.9996874,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03527075155297768,"score_gpt":0.3551255762284284,"score_spread":0.3198548246754507,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}